Home » Topics » Regulatory

Regulatory
RSS

Questcor Pharma's Acthar launched in U.S. for infantile spasms

Nov. 5, 2010

FDA approves Teflaro for CABP and ABSSSI in adults

Nov. 4, 2010

FDA approves Avanir's Nuedexta for treatment of pseudobulbar affect

Nov. 2, 2010

Sunovion receives FDA approval for its once-daily schizophrenia treatment Latuda

Oct. 29, 2010

FDA approves subcutaneous administration of Gamunex-C in primary immunodeficiency

Oct. 22, 2010

Twice-daily tramadol/acetaminophen approved in eight European countries

Oct. 15, 2010

Daiichi Sankyo launches gel formulation of Loxonin in Japan

Oct. 6, 2010

Baxter obtains approval in Austria for Preflucel influenza vaccine

Oct. 1, 2010

FDA approves Allergan's Ozurdex implants for noninfectious uveitis

Sep. 28, 2010

New oral contraceptive Beyaz receives FDA approval

Sep. 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...